Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas

被引:66
作者
Sonoda, Yukihiko [1 ]
Shibahara, Ichiyoo [1 ]
Kawaguchi, Tomohiro [1 ]
Saito, Ryuta [1 ]
Kanamori, Masayuki [1 ]
Watanabe, Mika [2 ]
Suzuki, Hiroyoshi [3 ]
Kumabe, Toshihiro
Tominaga, Teiji [1 ,4 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ Hosp, Div Pathol, Sendai, Miyagi, Japan
[3] Sendai Med Ctr, Dept Pathol, Sendai, Miyagi, Japan
[4] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 228, Japan
关键词
Anaplastic glioma; IDH mutation; 1p19q co-deletion; Location; IDH1; OLIGODENDROGLIOMAS; ENHANCEMENT; MUTATIONS; SURVIVAL; CELL;
D O I
10.1007/s10014-014-0211-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to determine if molecular alterations are associated with tumor location and radiological characteristics in anaplastic gliomas. We performed a retrospective analysis of 122 anaplastic gliomas for molecular alterations (IDH1/2 mutations, TP53 mutations, and 1p19q co-deletion) to compare MRI features (location and image characteristics). We observed that IDH mutation is strongly associated with frontal location (P = 0.001). However, 13 tumors not located in the cerebral cortex were IDH intact tumors (P < 0.0001). While IDH mutation and TP53 mutation are significantly associated with AA (p < 0.0001), IDH mutation and 1p19q co-deletion were significantly associated with AO/AOA (p < 0.0001). No tumors with IDH mutation and 1p19q co-deletion infiltrated the temporal lobe (P = 0.003). The tumors with 1p19q co-deletion and histologically diagnosed as AO/AOA were associated with contrast enhancement on MR images (p = 0.007, p = 0.002, respectively) and those with TP53 mutation had a weak association with sharp tumor borders (p = 0.043). MRI features might be useful to predict molecular profiles in anaplastic gliomas.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 17 条
[1]   Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 [J].
Cairncross, Gregory ;
Wang, Meihua ;
Shaw, Edward ;
Jenkins, Robert ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperriere, Normand ;
Curran, Walter ;
Mehta, Minesh .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :337-343
[2]   Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma [J].
Carrillo, J. A. ;
Lai, A. ;
Nghiemphu, P. L. ;
Kim, H. J. ;
Phillips, H. S. ;
Kharbanda, S. ;
Moftakhar, P. ;
Lalaezari, S. ;
Yong, W. ;
Ellingson, B. M. ;
Cloughesy, T. F. ;
Pope, W. B. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2012, 33 (07) :1349-1355
[3]   Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features [J].
Jenkinson, Michael D. ;
du Plessis, Daniel G. ;
Smith, Trevor S. ;
Joyce, Kathy A. ;
Warnke, Peter C. ;
Walker, Carol .
BRAIN, 2006, 129 :1884-1891
[4]   Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours [J].
Kim, J. W. ;
Park, C-K ;
Park, S-H ;
Kim, Y. H. ;
Han, J. H. ;
Kim, C-Y ;
Sohn, C-H ;
Chang, K-H ;
Jung, H-W .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (02) :224-227
[5]   Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin [J].
Lai, Albert ;
Kharbanda, Samir ;
Pope, Whitney B. ;
Tran, Anh ;
Solis, Orestes E. ;
Peale, Franklin ;
Forrest, William F. ;
Pujara, Kanan ;
Carrillo, Jose A. ;
Pandita, Ajay ;
Ellingson, Benjamin M. ;
Bowers, Chauncey W. ;
Soriano, Robert H. ;
Schmidt, Nils O. ;
Mohan, Sankar ;
Yong, William H. ;
Seshagiri, Somasekar ;
Modrusan, Zora ;
Jiang, Zhaoshi ;
Aldape, Kenneth D. ;
Mischel, Paul S. ;
Liau, Linda M. ;
Escovedo, Cameron J. ;
Chen, Weidong ;
Nghiemphu, Phioanh Leia ;
James, C. David ;
Prados, Michael D. ;
Westphal, Manfred ;
Lamszus, Katrin ;
Cloughesy, Timothy ;
Phillips, Heidi S. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (34) :4482-4490
[6]  
Levin VA, 2003, CLIN CANCER RES, V9, P981
[7]  
Louis DN., 2007, WHO CLASSIFICATION T
[8]   Non-Stem Cell Origin for Oligodendroglioma [J].
Persson, Anders I. ;
Petritsch, Claudia ;
Swartling, Fredrik J. ;
Itsara, Melissa ;
Sim, Fraser J. ;
Auvergne, Romane ;
Goldenberg, David D. ;
Vandenberg, Scott R. ;
Nguyen, Kim N. ;
Yakovenko, Stanislava ;
Ayers-Ringler, Jennifer ;
Nishiyama, Akiko ;
Stallcup, William B. ;
Berger, Mitchel S. ;
Bergers, Gabriele ;
McKnight, Tracy R. ;
Goldman, Steven A. ;
Weiss, William A. .
CANCER CELL, 2010, 18 (06) :669-682
[9]   Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms [J].
Qi, Songtao ;
Yu, Lei ;
Li, Hezhen ;
Ou, Yanghui ;
Qiu, Xiaoyu ;
Ding, Yanqing ;
Han, Huixia ;
Zhang, Xuelin .
ONCOLOGY LETTERS, 2014, 7 (06) :1895-1902
[10]   Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression [J].
Reyes-Botero, German ;
Dehais, Caroline ;
Idbaih, Ahmed ;
Martin-Duverneuil, Nadine ;
Lahutte, Marion ;
Carpentier, Catherine ;
Letouze, Eric ;
Chinot, Olivier ;
Loiseau, Hugues ;
Honnorat, Jerome ;
Ramirez, Carole ;
Moyal, Elisabeth ;
Figarella-Branger, Dominique ;
Ducray, Francois .
NEURO-ONCOLOGY, 2014, 16 (05) :662-670